Cantargia AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0006371126
SEK
4.12
-0.05 (-1.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Cantargia AB
Swedencare AB
Calliditas Therapeutics AB
Egetis Therapeutics AB
Oncopeptides AB
Hansa Biopharma AB
Xbrane Biopharma AB
Vicore Pharma Holding AB
Xspray Pharma AB
Infant Bacterial Therapeutics AB
FluoGuide A/S

Why is Cantargia AB ?

1
With a growth in Net Sales of INF%, the company declared Very Positive results in Dec 25
  • The company has declared positive results for the last 7 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at SEK 150.14 MM
  • NET PROFIT(HY) Higher at SEK 233.17 MM
  • ROCE(HY) Highest at 76.91%
2
With ROE of -537.32%, it has a does not qualify valuation with a 20.20 Price to Book Value
  • Over the past year, while the stock has generated a return of 172.52%, its profits have risen by 24.9%
3
Market Beating Performance
  • The stock has generated a return of 172.52% in the last 1 year, much higher than market (OMX Stockholm 30) returns of 10.97%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Cantargia AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Cantargia AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Cantargia AB
172.52%
-0.04
269.45%
OMX Stockholm 30
10.97%
0.59
18.59%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
216.52%
EBIT Growth (5y)
23.65%
EBIT to Interest (avg)
-258.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.49
Sales to Capital Employed (avg)
1.11
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
20.20
EV to EBIT
-3.40
EV to EBITDA
-3.47
EV to Capital Employed
-20.16
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-537.32%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 150.14 MM

NET PROFIT(HY)

Higher at SEK 233.17 MM

ROCE(HY)

Highest at 76.91%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

NET SALES(9M)

Higher at SEK 316.7 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 4.75 times

-8What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 0 %

INTEREST(Q)

Highest at SEK 6.36 MM

Here's what is working for Cantargia AB

Net Profit
At SEK 233.17 MM has Grown at 386.43%
Year on Year (YoY)
MOJO Watch
Net Profit trend is very positive

Net Profit (SEK MM)

Net Sales
At SEK 316.7 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (SEK MM)

Operating Cash Flow
Highest at SEK 150.14 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Profit
Higher at SEK 233.17 MM
than preceding 12 month period ended Dec 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

Debtors Turnover Ratio
Highest at 4.75 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Higher at SEK 316.7 MM
than preceding 12 month period ended Dec 2025
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (SEK MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cantargia AB

Interest
At SEK 6.36 MM has Grown at 71.88%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Interest
Highest at SEK 6.36 MM
in the last five periods and Increased by 71.88% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio